We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App





Sugar-Coated COVID-19 Test Strip Detects All Known Coronavirus Variants

By LabMedica International staff writers
Posted on 16 Dec 2021
Print article
Illustration
Illustration

Researchers have taken advantage of the coronavirus’ sweet tooth by designing a sugar-coated COVID-19 test strip that has proved effective at detecting all known variants of the virus, including delta.

In the next few weeks, researchers at the University of North Carolina at Chapel Hill (Chapel Hill, NC, USA) and University of California San Diego (La Jolla, CA, USA) will determine if the self-test known as GlycoGrip can detect infections caused by the omicron variant as well. The test is inspired by the natural biology of epithelial cells – those that are targeted and infiltrated by SARS-CoV-2, the virus that causes COVID-19. These cells are coated with a dense matrix of sugars called the glycocalyx, and it’s this sugar net that the virus exploits to cause infection.

The concept is intuitive: a droplet of biofluid containing the virus, such as saliva, is placed on one end of the strip and flows along the surface. When the fluid reaches a sugar-coated patch, the virus can’t help but indulge its sweet tooth, becoming trapped on that specific area. This capture is then signaled by antibodies treated with gold nanoparticles producing a visual color that indicates infection.

To better understand how these sugar polymers bind the virus, the team developed computationally intensive simulations that helped explain the mechanics behind how and why the cell-anchored sugars bind the viral spikes. One of the greatest challenges of the ongoing COVID-19 pandemic has been responding to the virus’ mutations and emerging variants. New tests must be developed for new tweaks in the virus’ genetic code. But GlycoGrip offers a solution for universal coronavirus testing.

“We have turned the tables on the virus by using the same sugar coat it binds to infect cells – to capture it into our sensor,” said Carolina researcher Ronit Freeman. “We tapped into nature to reimagine viral diagnostics. We are optimistic that GlycoGrip will capture future variants just as easily.”

“By using atomic-level views of the spike protein, we were able to identify key binding sites for the glycocalyx sugar polymers and unlock how these sugars adapt to different spike conformations,” said Rommie Amaro, professor of chemistry and biochemistry at the University of California San Diego. “This is exciting, we essentially revealed another secret of how spike binds cells to facilitate infection.”

Related Links:
University of North Carolina at Chapel Hill 
University of California San Diego 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.